Global RNA Next-Generation Sequencing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 188974
  • calendar_today Published On: Aug, 2019
  • file_copy Pages: 115
  • list Pharmaceuticals and Healthcare

RNA next-generation sequencing refer to the use of next-generation sequencing to reveal the presence and quantity of RNA in a biological sample at a given moment.

Scope of the Report:

The global RNA Next-Generation Sequencing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of RNA Next-Generation Sequencing.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the RNA Next-Generation Sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the RNA Next-Generation Sequencing market by product type and applications/end industries.

Market Segment by Companies, this report covers

Roche

Illumina

Thermo Fisher Scientific

Beckman Coulter

Abbott Molecular

Pacific Biosciences

Oxford Nanopore Technologies

Eurofins Scientific

Macrogen

GENEWIZ

BGI

Berry Genomics

QIAGEN

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Enrichment Approaches

Amplicon-Based Approaches

Market Segment by Applications, can be divided into

Research Institutes

Hospitals and Clinics

Biotechnology Company

Diagnostic Lab

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 RNA Next-Generation Sequencing Market Overview

1.1 Product Overview and Scope of RNA Next-Generation Sequencing

1.2 Classification of RNA Next-Generation Sequencing by Types

1.2.1 Global RNA Next-Generation Sequencing Revenue Comparison by Types (2019-2024)

1.2.2 Global RNA Next-Generation Sequencing Revenue Market Share by Types in 2018

1.2.3 Enrichment Approaches

1.2.4 Amplicon-Based Approaches

1.3 Global RNA Next-Generation Sequencing Market by Application

1.3.1 Global RNA Next-Generation Sequencing Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Research Institutes

1.3.3 Hospitals and Clinics

1.3.4 Biotechnology Company

1.3.5 Diagnostic Lab

1.4 Global RNA Next-Generation Sequencing Market by Regions

1.4.1 Global RNA Next-Generation Sequencing Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) RNA Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) RNA Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNA Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) RNA Next-Generation Sequencing Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNA Next-Generation Sequencing Status and Prospect (2014-2024)

1.5 Global Market Size of RNA Next-Generation Sequencing (2014-2024)

2 Manufacturers Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 RNA Next-Generation Sequencing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.2 Illumina

2.2.1 Business Overview

2.2.2 RNA Next-Generation Sequencing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Illumina RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.3 Thermo Fisher Scientific

2.3.1 Business Overview

2.3.2 RNA Next-Generation Sequencing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Thermo Fisher Scientific RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.4 Beckman Coulter

2.4.1 Business Overview

2.4.2 RNA Next-Generation Sequencing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Beckman Coulter RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.5 Abbott Molecular

2.5.1 Business Overview

2.5.2 RNA Next-Generation Sequencing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Abbott Molecular RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.6 Pacific Biosciences

2.6.1 Business Overview

2.6.2 RNA Next-Generation Sequencing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pacific Biosciences RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.7 Oxford Nanopore Technologies

2.7.1 Business Overview

2.7.2 RNA Next-Generation Sequencing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Oxford Nanopore Technologies RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.8 Eurofins Scientific

2.8.1 Business Overview

2.8.2 RNA Next-Generation Sequencing Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Eurofins Scientific RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.9 Macrogen

2.9.1 Business Overview

2.9.2 RNA Next-Generation Sequencing Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Macrogen RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.10 GENEWIZ

2.10.1 Business Overview

2.10.2 RNA Next-Generation Sequencing Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 GENEWIZ RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.11 BGI

2.11.1 Business Overview

2.11.2 RNA Next-Generation Sequencing Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 BGI RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.12 Berry Genomics

2.12.1 Business Overview

2.12.2 RNA Next-Generation Sequencing Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Berry Genomics RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

2.13 QIAGEN

2.13.1 Business Overview

2.13.2 RNA Next-Generation Sequencing Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 QIAGEN RNA Next-Generation Sequencing Revenue, Gross Margin and Market Share (2017-2018)

3 Global RNA Next-Generation Sequencing Market Competition, by Players

3.1 Global RNA Next-Generation Sequencing Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 RNA Next-Generation Sequencing Players Market Share

3.2.2 Top 10 RNA Next-Generation Sequencing Players Market Share

3.3 Market Competition Trend

4 Global RNA Next-Generation Sequencing Market Size by Regions

4.1 Global RNA Next-Generation Sequencing Revenue and Market Share by Regions

4.2 North America RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.3 Europe RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.5 South America RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

5 North America RNA Next-Generation Sequencing Revenue by Countries

5.1 North America RNA Next-Generation Sequencing Revenue by Countries (2014-2019)

5.2 USA RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

5.3 Canada RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

5.4 Mexico RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6 Europe RNA Next-Generation Sequencing Revenue by Countries

6.1 Europe RNA Next-Generation Sequencing Revenue by Countries (2014-2019)

6.2 Germany RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.3 UK RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.4 France RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.5 Russia RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

6.6 Italy RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific RNA Next-Generation Sequencing Revenue by Countries

7.1 Asia-Pacific RNA Next-Generation Sequencing Revenue by Countries (2014-2019)

7.2 China RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.3 Japan RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.4 Korea RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.5 India RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

8 South America RNA Next-Generation Sequencing Revenue by Countries

8.1 South America RNA Next-Generation Sequencing Revenue by Countries (2014-2019)

8.2 Brazil RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

8.3 Argentina RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

8.4 Colombia RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue RNA Next-Generation Sequencing by Countries

9.1 Middle East and Africa RNA Next-Generation Sequencing Revenue by Countries (2014-2019)

9.2 Saudi Arabia RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.3 UAE RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.4 Egypt RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.5 Nigeria RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

9.6 South Africa RNA Next-Generation Sequencing Revenue and Growth Rate (2014-2019)

10 Global RNA Next-Generation Sequencing Market Segment by Type

10.1 Global RNA Next-Generation Sequencing Revenue and Market Share by Type (2014-2019)

10.2 Global RNA Next-Generation Sequencing Market Forecast by Type (2019-2024)

10.3 Enrichment Approaches Revenue Growth Rate (2014-2024)

10.4 Amplicon-Based Approaches Revenue Growth Rate (2014-2024)

11 Global RNA Next-Generation Sequencing Market Segment by Application

11.1 Global RNA Next-Generation Sequencing Revenue Market Share by Application (2014-2019)

11.2 RNA Next-Generation Sequencing Market Forecast by Application (2019-2024)

11.3 Research Institutes Revenue Growth (2014-2019)

11.4 Hospitals and Clinics Revenue Growth (2014-2019)

11.5 Biotechnology Company Revenue Growth (2014-2019)

11.6 Diagnostic Lab Revenue Growth (2014-2019)

12 Global RNA Next-Generation Sequencing Market Size Forecast (2019-2024)

12.1 Global RNA Next-Generation Sequencing Market Size Forecast (2019-2024)

12.2 Global RNA Next-Generation Sequencing Market Forecast by Regions (2019-2024)

12.3 North America RNA Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.4 Europe RNA Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific RNA Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.6 South America RNA Next-Generation Sequencing Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa RNA Next-Generation Sequencing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure RNA Next-Generation Sequencing Picture

Table Product Specifications of RNA Next-Generation Sequencing

Table Global RNA Next-Generation Sequencing and Revenue (Millio

Please fill the form below, to recieve the report sample


+1